During a press conference with the authorities of the World Health Organization (WHO), Quiroga announced that the South American giant will receive 500 million shares of medicines by the end of 2021, but he requested donations to countries with surplus quantities. “We reiterate our request to those (countries) that have additional doses of vaccines to share with Brazil as soon as possible,” he said, adding that the contribution would allow “progress in the intensive vaccination campaign.”
He pointed to the fact that the country has chosen a differentiated strategy, which includes partnerships for technology transfer and national production, bilateral contracts with pharmaceutical companies, and participation in the Covax mechanism, which is a multilateral project.
At the same conference, hypothetically, the Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, admitted that Brazil is one of the countries most affected by the epidemic, but that “Coronavirus cases have decreased in the past four weeks.”
He said that this is good news and we hope that this trend will continue, adding that “the epidemic has taught us that no country can lower its caution.”
By May, Brazil should have 34.5 million doses of immunity, according to the latest calendar released by the Ministry of Health.
This perspective adds the CoronaVac vaccines, from the Sinovac Chinese Laboratory produced by the Botantan Institute in São Paulo, and the University of Oxford (UK) vaccines and the Anglo-Swedish AstraZeneca Company, prepared by the Oswaldo Cruz Foundation (Fiocruz) in Rio, Janeiro.
Likewise, the US laboratory Pfizer, the German company BioNTech, and those of the WHO’s Covax consortium.
So far, Brazil has accumulated 403,000 781 deaths and 14 million 659,000 11 people infected with SARS-CoV-2, which causes Covid-19.
jf / ocs